‘Groundbreaking,’ First-in-human total artificial heart implanted inside patient in Houston

THI and BiVACOR announced the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024.